• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

    • Radiology
      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Electrospun Construct Mimics Elasticity of Blood Vessels

      Electrospun Construct Mimics Elasticity of Blood Vessels

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Rare Disease Genetic Testing Market Share Expected to Grow Over USD 2,414.90 Million by 2030: Polaris Market Research

November 4th, 2022 Polaris Market Research Releases

Polaris Market Research recently published [115+ Pages] research report on “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests); By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 – 2030” in its research database.

According to the research report, the global rare disease genetic testing market share was valued at USD 784.32 million in 2021 and is expected to reach USD 2,414.90 Million By 2030, growing at a CAGR of 13.9% during the forecast period.

What is Rare Disease Genetic Testing? How Big is Rare Disease Genetic Testing Market Share?

  • Overview

Genetic testing is a kind of medical test which considers changes in genes, proteins, or chromosomes. It is correlated with several ethical challenges in a single organization and a huge level of healthcare methods. The test results of this test can be confirmed after having a suspension of the genetic condition or helps in determining an individual’s risk.

Moreover, various tests are utilized to identify infrequent genetic diseases, that includes Duchenne muscular dystrophy and fragile x syndrome. Advancement in technology is the major factor propelling the global rare disease genetic testing market demand. Also, the rising frequency of chronic diseases across the globe is uplifting the industry.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-sample

Reasons to Purchase This Report

  • The report covers all current and future probabilities in the market.
  • The report assists in redeveloping business strategies based on key priorities.
  • The report identifies the segment likely to witness considerable growth and revenue maximization.
  • The report delivers relevant data on future-ready expansion plans related to the industry.
  • The report provides an in-depth assessment of market opportunities available in leading regions

Some of the Top Companies Are:

  • 3billion Inc.
  • Ambry Genetics
  • Artemis DNA
  • Arup Laboratories
  • Baylor Genetics
  • Centogene N.V.
  • Color Genomics Inc.
  • Coopersurgical Inc.
  • Eurofins Scientific
  • Fulgent Genetics Inc.
  • Genomenon
  • Health Network Laboratories
  • Invitae Corp.
  • Laboratory Corporation of America Holdings
  • Macrogen Inc.
  • Myriad Genetics Inc.
  • Opko Health Inc.
  • Perkin Elmer Inc.
  • PreventionGenetics
  • Progenity Inc.
  • Quest Diagnostics Inc.
  • Realm IDX Inc.
  • Strand Life Sciences

To Know Additional Information on Market Players, Download Sample PDF Brochure

Growth Factors Contributing to the Market

The rare disease genetic testing market share is uplifting due to reducing the price of sequencing. Also, rising advanced data collection, higher-quality registries, and interpretation technologies utilized in clinical practices are anticipated to boost the global market over the foreseen period. Rising government initiatives towards this market are estimated to drive the market.

Furthermore, rising product innovation for rare disorder diagnosis uplifts the global market. The evolution of customized trial kits for determining therapeutic areas is responsible for the rising rare disease genetic testing market size. The reproving role of interpretation research & genomic technologies to uplift the examination and recognition of new modifications is anticipated to boost the global market.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/7391

Recent Developments

  • In December 2020, Cell ID Pte. Ltd., a Singapore-based company that manufactures genetic testing products, will launch the Quiz PCR Biochip, a portable genetic test for COVID-19.
  • In January 2022, Exact Sciences, a US-based manufacturer of genetic testing tools and a molecular diagnostics company, acquired Prevention Genetics for $190 million. Exact Sciences hopes to increase hereditary cancer testing for more patients as a result of this acquisition.

Segmental Analysis

  • Endocrine and metabolism diseases are considered the highest market share

On the basis of disease type, the global endocrine and metabolism diseases segment is accounted for the largest market share in 2021 and anticipated to maintain its dominance over the foreseen period. The factors responsible for the segment’s dominance are the rising requirement for molecular and genetic causes of endocrine disorders, including Cushing’s syndrome, to propel the segment’s growth.

  • Next-generation sequencing technology held the highest market share

Based on technology, the next-generation sequencing segment accounted for the largest market share in 2021. This is due to the increasing use of next-generation sequencing-based gene panels for neurologic disease, cancer, pediatric conditions, cardiovascular disease, psychiatric disorders, and other disease testing that propelled the market.

  • The research lab & CROs segment is dominating the industry

On the basis of end-use, the rare disease genetic testing market segment is divided into research laboratories & cros, hospitals & clinics, and diagnostic laboratories. Out of all the research, lab and CROs are considered the largest revenue for the rare disease genetic testing market industry.

Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-discount-pricing

Rare Disease Genetic Testing Market: Report Scope

Report Attribute Details
Market Outlook for 2030 USD 2,414.90 Million
Market Size 2022 Value USD 852.32 million
Expected CAGR Growth 13.9% from 2022 – 2030
Base Year 2021
Forecast Year 2022 – 2030
Top Market Players 3billion, Inc., Ambry Genetics, Artemis DNA, Arup Laboratories, Baylor Genetics, Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific, Fulgent Genetics Inc., Genomenon, Health Network Laboratories, Invitae Corp., Laboratory Corporation of America Holdings, Macrogen, Inc., Myriad Genetics, Inc., Opko Health, Inc., Perkin Elmer, Inc., PreventionGenetics, Progenity, Inc., Quest Diagnostics Inc., Realm IDX, Inc., Strand Life Sciences.
Segments Covered By Disease Type, By Technology, By Specialty, By End-Use, By Region
Customization Options Customized purchase options are available to meet your research needs. Explore customized purchase options

 Geographic Overview

  • North American region is considered the largest market share

On the basis of geography, the North American region is anticipated to account for the highest market share during the assessment period. This segment held the largest rare disease genetic testing market share due to the rising frequency of numerous disease registries, rare diseases, a significant number of research and development centers for ultra-rare disorders, and considerable investments in disease observation.

Browse the Detail Report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests); By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market

For Additional Information OR Media Enquiry, Please Mail Us At: sales@polarismarketresearch.com

Key Questions Answered in The Report

  • Who are the competitors in the market?
  • What are the prime drivers, growth/decline factors, and challenges?
  • How is the industry expected to evolve in the forecasted period?
  • What are the consumption patterns across the various regions?
  • Which are the key areas of applications and product types that may expect a huge demand in the upcoming period?
  • What factors make the market a good long-term investment?
  • What are the top firms’ tactics for gaining a share in the market?

Polaris Market Research has segmented the rare disease genetic testing market report based on disease type, technology, specialty, end-use, and regions:

By Disease Type Outlook

  • Neurological Disease
  • Immunological Disorders
  • Hematology Diseases
  • Endocrine & Metabolism Diseases
  • Cancer
  • Musculoskeletal Disorders
  • Cardiovascular Disorders
  • Dermatology Disease
  • Others

By Technology Outlook

  • Next-Generation Sequencing
  • Whole Exome
  • Whole Genome
  • Array Technology
  • PCR-based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

By specialty Outlook

  • Molecular Genetic Tests
  • Chromosomal Genetic Tests
  • Biochemical, Genetic Tests

By End Use Outlook

  • Research Laboratories & Cros
  • Hospitals & Clinics
  • Diagnostic Laboratories

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Related Reports:

  • Pharmaceutical Aseptic Transfer Market: https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-aseptic-transfer-market
  • Legionella Testing Market: https://www.polarismarketresearch.com/industry-analysis/legionella-testing-market
  • Biologics Contract Development Market: https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market
  • Patient Referral Management Software Market: https://www.polarismarketresearch.com/industry-analysis/patient-referral-management-software-market
  • Nuclear Magnetic Resonance Spectroscopy Market: https://www.polarismarketresearch.com/industry-analysis/nuclear-magnetic-resonance-spectroscopy-market

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G

30 Wall Street

8th Floor,

New York City, NY 10005,

United States

Phone: +1-929 297-9727

Email: sales@polarismarketresearch.com

Web: https://www.polarismarketresearch.com

Follow US: LinkedIn | twitter

Sign up and submit a press release

Sponsored
New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email